Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.9%

6 terminated out of 76 trials

Success Rate

87.8%

+1.2% vs benchmark

Late-Stage Pipeline

5%

4 trials in Phase 3/4

Results Transparency

23%

10 of 43 completed with results

Key Signals

10 with results88% success

Data Visualizations

Phase Distribution

55Total
Not Applicable (15)
Early P 1 (1)
P 1 (17)
P 2 (18)
P 3 (4)

Trial Status

Completed43
Unknown13
Terminated6
Withdrawn5
Active Not Recruiting3
Not Yet Recruiting3

Trial Success Rate

87.8%

Benchmark: 86.5%

Based on 43 completed trials

Clinical Trials (76)

Showing 20 of 20 trials
NCT07469592Not ApplicableNot Yet RecruitingPrimary

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

NCT07372885Phase 1Not Yet Recruiting

GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

NCT06077734Terminated

Muscle Stem Cell Quality in Atrophy

NCT05968963Not ApplicableActive Not RecruitingPrimary

Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

NCT04511130Phase 2Terminated

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

NCT07219524Not ApplicableCompletedPrimary

Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Feasibility Study

NCT02300961Not ApplicableActive Not RecruitingPrimary

Feasibility Neurocognitive Outcome After Transplant

NCT06743477Not ApplicableRecruitingPrimary

A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme

NCT04789863Not ApplicableCompletedPrimary

Implementation and Testing of an eHealth Integrated Model of Care for Patients Receiving Allogeneic Stem Cell Transplantation: The SMILe Project

NCT03918343Not ApplicableCompleted

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

NCT02105766Phase 2Active Not Recruiting

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

NCT00179855Phase 2Completed

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

NCT00179868Completed

C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

NCT05438823Not ApplicableCompletedPrimary

Technology Supported Education Program Based on Human Care Theory

NCT06692868Recruiting

Fertility Protection for Children, Adolescents and Young Adults

NCT05477589Phase 3Recruiting

Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

NCT06506396Not Yet RecruitingPrimary

Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

NCT06134297Not ApplicableUnknownPrimary

Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation

NCT05293509Phase 2WithdrawnPrimary

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

NCT05494671Not ApplicableUnknownPrimary

Studying Corneal Epithelial Stability Following Limbal Stem Cell Transplantation in Cases of Limbal Stem Cell Deficiency

Scroll to load more

Research Network

Activity Timeline